Life Sciences & Health Care

This report explores how cross-sector, place-based coalitions align stakeholders, capabilities and resources to turn ambition into action, using NCD outcomes as a use case.

Welcome to the 16th edition of Measuring the return from pharmaceutical innovation. This year, the analysis shows an industry at an inflection point.

From digital health to biotech and from digital therapeutics to health care IT innovations, there’s a community and a conversation about it at HLTH Europe event.

Insight into emerging trends and leadership priorities as life sciences executives respond to industry shifts, innovation, and new challenges shaping 2026.

Insight into evolving strategies, priorities, and opportunities as health care leaders navigate transformation, innovation, and uncertainty across the industry in 2026.

AI is reshaping health care, but success relies on strong risk governance and trust. The Ottawa Hospital, with support from Deloitte, demonstrates how thoughtfully implemented AI can lighten clinicians’ workloads, enhance patient care, and create space for genuine compassion and expertise.

Federal health agencies can harness AI to improve the efficiency of both health services and government operations

Insights and learnings for Japanese life sciences organizations that are globalizing to fulfill growth ambitions. Driven by domestic economic and industry-specific challenges, many Japan-headquartered life sciences organizations are looking at greater globalization as a catalyst for growth and innovation. This report highlights this trend via executive interviews across Japanese life sciences (LS) organizations, non-Japanese LS organizations, and cross-industry Japanese organizations.

Welcome to the fourth of a series of life sciences and healthcare predictions reports, comprising ten predictions exploring how the world could look in 2030, what it might feel like for different stakeholders in the health ecosystem, the evidence today that informs our views of tomorrow and how AI technologies, specifically GenAI, might help bring the future closer.

The Future of Health Series is a dynamic collection of webcasts designed to spark conversations and drive meaningful change across the health care landscape.

In this report, Project HOPE and Deloitte US have brought together frontline health care workers, program leaders, health system advisors, policy and advocacy professionals, community leaders, and strategic relationships to collaborate on potential solutions for enhancing climate resilience.

Platform businesses are rewiring the traditional value chain. In nearly every industry, well-thought-out platform businesses typically beat traditional businesses because of superior unit economics and network effects.

Deloitte's Electronic Health Record (EHR) solution helps health systems execute digital transformation that shifts legacy models into modern best practices anchored on elevating the human experience.

Measuring the return from pharmaceutical innovation – 14th edition